Nottingham Therapeutics Ltd
NT is developing an exciting and innovative biopolymer technology platform primarily for use in the growing non-surgical cosmetic arena of volumetric and rejuvenation dermal implants and 'fillers'. Its first product, ADIGel, is being developed as a dermal filler and this technology will be expanded into new areas including repair of arthritic joints, skin cancer and chronic wounds such as burns and non-healing ulcers.